Table 2. Evaluation of classifiers as indicators of tumor infiltration.
Nuclear density, axonal density, and protein:lipid ratio were measured for each of the 1477 300×300 μm2 FOVs from 51 fresh tissue biopsies from 18 patients. A quasi-likelihood approach with a GAM was used to incorporate all of the attributes into a single classifier. Half of the FOVs (n=738) were used to create the classifier, which was then tested on the other half of the data (n=739). Given that glioma can be more difficult to distinguish from normal tissue than metastases and extra-axial tumors, a quasi-likelihood generalized additive model (GAM) was also used on a subset of tumors, excluding all non-glial tumors, to create the glioma-only classifier. To eliminate correlation between the testing set and training set, we used a leave-one-out cross-validation approach. The leave-one-out cross-validation was performed in a data set excluding non-glioma patients.
Classification condition | Area under curve | Mean sensitivity (%) | 95% CI | Mean specificity (%) | 95% CI |
---|---|---|---|---|---|
GAM (all subjects) | |||||
| |||||
Normal vs. abnormal | 0.995 | 97.5 | 95.9–98.9 | 98.5 | 97.0–99.7 |
Normal vs. infiltrating | 0.988 | 94.7 | 91.4–98.9 | 98.5 | 97.0–99.5 |
Normal vs. dense | 0.989 | 98.0 | 95.6–100 | 99.0 | 97.4–100 |
| |||||
GAM (glioma only) | |||||
| |||||
Normal vs. abnormal | 0.994 | 97.0 | 95.0–98.7 | 98.7 | 97.2–99.5 |
Normal vs. infiltrating | 0.988 | 94.9 | 91.3–98.1 | 98.5 | 97.1–99.5 |
Normal vs. dense | 0.990 | 98.2 | 95.1–100 | 99.0 | 98.2–100 |
| |||||
Leave-one-out cross-validation | |||||
| |||||
Normal vs. abnormal | 0.893 | 87.3 | n/a | 87.5 | n/a |
Normal vs. infiltrating | 0.911 | 82.8 | n/a | 95 | n/a |
Normal vs. dense | 0.908 | 83.9 | n/a | 93.3 | n/a |
CI, confidence interval.